with Maria Fleseriu, MD, FACE, and Vivien Herman-Bonert, MD
Cushing's disease, an uncommon but hard to treat endocrine disorder, occurs when a tumor on the pituitary gland, called an adenomathat is almost always benignleads to an overproduction of ACTH (adrenocorticotropic hormone), which is responsible for stimulating the release of cortisol, also known as the stress hormone.
Until now, surgery to remove the non-cancerous but problematic tumor has been the only effective treatment. Still, many patients will require medication to help control their serum cortisol levels, and others cannot have surgery or would prefer to avoid it.
Finally, a drug proves effective as added on or alternative to surgery in managing Cushing's disease. Photo; 123rf
Now, there is good news about long-term positive results achieved with pasireotide (Signifor)the first medication to demonstrate effectiveness in both normalizing serum cortisol levels and either shrinking or slowing growth of tumors over the long term.1,2 These findings appear in the journal, Clinical Endocrinology, showing that patients followed for 36 months as part of an ongoing study had improved patient outcomes for Cushings disease.2
"What we knew before this extension study wasthe drug will work in approximately half of the patients with mild Cushing's disease," says study author Maria Fleseriu, MD, FACE, director of the Northwest Pituitary Center and professor of neurological surgery and medicine in the division of endocrinology, diabetes and clinical nutrition at the Oregon Health and Sciences University School of Medicine.
Pasireotide also offers good clinical benefits," says Dr. Fleseriu who is also the president of the Pituitary Society, which includes improvements in blood pressure, other signs and symptoms of Cushings symptom], and quality of life.2
Among the signs and symptoms of Cushings disease that are lessened with treatment are:3
The accumulation of adipose tissue raises the risk of heart disease, which adds to the urgency of effective treatment. In addition, many individuals who have Cushings disease also complain of quality of life issues such as fatigue, depression, mood and behavioral problems, as well as poor memory.2
As good as the results appear following the longer term use of pasireotide,2 Dr. Fleseriu admits that in any extension study in which patients are asked to continue on, there are some built-in limitations, which may influence the findings. For example, patients who agree to stay on do so because they are good responders, meaning they feel better, so theyre happy to stick with the study.
Fortunately, for the patients who have responded to pasireotide initially, this is a drug that can be continued as there are no new safety signals with longer use," Dr. Fleseriu tells EndocrineWeb, "and when the response at the start is good, very few patients will lose control of their urinary free cortisol over time. That's a frequent marker used to monitor patient's status. For those patients with large tumors, almost half of them had a significant shrinkage, and all the others had a stable tumor size."
What Are the Reasons to Consider Drug Treatment to Manage Cushings Symptoms
The extension study ''was important because we didn't have any long-term data regarding patient response to this once-a-month treatment to manage Cushing's disease," she says.
While selective surgical removal of the tumor is the preferred treatment choice, the success rate in patients varies, and Cushing's symptoms persist in up to 35% of patients after surgery. In addition, recurrent rates (ie, return of disease) range from 13% to 66% after individuals experience different durations remaining in remission.1
Therefore, the availability of an effective, long-lasting drug will change the course of therapy for many patients with Cushings disease going forward. Not only will pasireotide benefit patients who have persistent and recurrent disease after undergoing surgery, but also this medication will be beneficial for those who are not candidates for surgery or just wish to avoid having this procedure, he said.
This long-acting therapy, pasireotide, which is given by injection, was approved in the US after reviewing results of a 12-month Phase 3 trial.1 In the initial study, participants had a confirmed pituitary cause of the Cushing's disease. After that, the researchers added the optional 12-month open-label, extension study, and now patients can continue on in a separate long-term safety study.
Those eligible for the 12-month extension had to have mean urinary free cortisol not exceeding the upper limit of normal (166.5 nanomoles per 24 hour) and/or be considered by the investigator to be getting substantial clinical benefit from treatment with long-action pasireotide, and to demonstrate tolerability of pasireotide during the core study.1
Of the 150 in the initial trial, 81 participants, or 54% of the patients, entered the extension study. Of those, 39 completed the next phase, and most also enrolled in another long-term safety studythese results not yet available).2
During the core study, 1 participants were randomly assigned to 10 or 30 mg of the drug every 28 days, with doses based on effectiveness and tolerability. When they entered the extension, patients were given the same dose they received at month.1,2
Of those who received 36 months of treatment with pasireotide, nearly three in four (72.2%) had controlled levels of urinary free cortisol at this time point.2 Equally good news for this drug was that tumors either shrank or did not grow. Of those individuals who started the trial with a measurable tumor (adenoma) as well as those with an adenoma at the two year mark (35 people), 85.7% of them experienced a reduction of 20% or more or less than a 20% change in tumor volume. No macroadenomas present at the start of the study showed a change of more than 20% at either month 24 or 36.2
Improvements in blood pressure, body mass index (BMI) and waist circumference continued throughout the extension study.1 Those factors influence CVD risk, the leading cause of death in those with Cushing's.4
As for adverse events, most of the study participants, 91.4%, did report one or more complaint during the extension studymost commonly, it was high blood sugar, which was reported by nearly 40% of participants.2. This is not surprising when you consider that most (81.5%) of the individuals participating in the extension trial entered with a diagnosis of diabetes or use of antidiabetic medication, and even more of them (88.9%) had diabetes at the last evaluation.1
This complication indicates the need for people with Cushings disease to check their blood glucose, as appropriate.
Women typically develop Cushings disease more often than men.
What else should you be aware of if you and your doctor decide this medication will help you? Monitoring is crucial, says Dr. Fleseriu, as you will need to have your cortisol levels checked, and you should be on alert for any diabetes signals, which will require close monitoring and regular follow-up for disease management.
Another understanding gained from the results of this drug study: "This medication works on the tumor level," she says. "If the patient has a macroadenoma (large tumor), this would be the preferred treatment." However, it should be used with caution in those with diabetes given the increased risk of experiencing high blood sugar.
The researchers conclude that "the long-term safety profile of pasireotide was very favorable and consistent with that reported during the first 12 months of treatment. These data support the use of long-acting pasireotide as an effective long-term treatment option for some patients with Cushing's Disease."1
Vivien S. Herman-Bonert, MD, an endocrinologist and clinical director of the Pituitary Center at Cedars-Sinai Medical Center in Los Angeles, agreed to discuss the study findings, after agreeing to review the research for EndocrineWeb.
As to who might benefit most from monthly pasireotide injections? Dr. Herman-Bonert says, "any patient with Cushing's disease that requires long-term medical therapy, which includes patients with persistent or recurrent disease after surgery." Certainly, anyone who has had poor response to any other medical therapies for Cushing's disease either because they didn't work well enough or because the side effects were too much, will likely benefit a well, she adds.
Among the pluses that came out of the study, she says, is that nearly half of the patients had controlled average urinary free cortisol levels after two full years, and 72% of the participants who continued on with the drug for 36 months were able to remain in good urinary cortisol control .1
As the authors stated, tumor shrinkage was another clear benefit of taking long-term pasireotide. That makes the drug a potentially good choice for those even with large tumors or with progressive tumor growth, she says. Its always good for anyone with Cushings disease to have an alterative to surgery, or a back-up option when surgery isnt quite enough, says Dr. Herman-Bonert.
The best news for patients is that quality of life scores improved,1 she adds.
Dr Herman-Bonert did add a note of caution: Although the treatment in this study is described as ''long-term, patients will need to be on this for far longer than 2 to 3 years," she says. So, the data reported in this study may or may not persist, and we dont yet know what the impact will be 10 or 25 years out.
Also, the issue of hyperglycemia-related adverse events raises a concern, given the vast majority (81%) of patients who have both Cushings disease and diabetes. Most of those taking this drug had a dual diagnosishaving diabetes, a history of diabetes, or taking antidiabetic medicine.
If you are under care for diabetes and you require treatment for Cushings disease, you must be ver mindful that taking pasireotide will likely lead to high blood sugar spikes, so you should plan to address this with your healthcare provider.
Dr. Fleseriu reports research support paid to Oregon Health & Science University from Novartis and other 0companies and consultancy fees from Novartis and Strongbridge Biopharma. Dr. Herman-Bonert has no relevant disclosures.
The study was underwritten by Novartis Pharma AG, the drug maker.
Last updated on 09/27/2019
Multimodal Approach Promises Best Outcomes for Cushing's Disease
Visit link:
Cushing's DiseaseMonthly Injection Is Good Alternative to Surgery - EndocrineWeb
- Ed's Guide to Alternative Therapies - pathguy.com - December 8th, 2016 [December 8th, 2016]
- Complementary and Alternative Medicine Guide | University ... - December 8th, 2016 [December 8th, 2016]
- Complementary and Alternative Medicine (CAM) Overview - December 26th, 2016 [December 26th, 2016]
- Alternative Medicine, Holistic Doctors,Naturopathic ... - January 5th, 2017 [January 5th, 2017]
- Alternative Medicine Degrees - Excite Education - January 13th, 2017 [January 13th, 2017]
- Alternative Medicine | Category | Fox News - January 13th, 2017 [January 13th, 2017]
- Alternative Medicine - Disabled World - January 13th, 2017 [January 13th, 2017]
- Alternative Medicine Degree, BS - Everglades University - January 23rd, 2017 [January 23rd, 2017]
- Alternative Medicine | Duke University Press - January 23rd, 2017 [January 23rd, 2017]
- Bill to rein in alternative medicine practitioners - Bangalore Mirror - February 8th, 2017 [February 8th, 2017]
- Peroxide ingestion, promoted by alternative medicine, can be deadly - Science Daily - February 8th, 2017 [February 8th, 2017]
- Can Peroxide Kill You? Yes, Say Doctors About This Alternative Medicine Favorite - Medical Daily - February 8th, 2017 [February 8th, 2017]
- Marijuana tension between clinical, alternative medicine ... - Washington Times - February 9th, 2017 [February 9th, 2017]
- Cannabis providers feel tension between clinical and alternative medicine - The Cannabist - February 11th, 2017 [February 11th, 2017]
- Happy Healthy YOU - Tillsonburg News - February 15th, 2017 [February 15th, 2017]
- Health dept cracks down on alternative meds containing sildenafil citrate - NYOOOZ - February 18th, 2017 [February 18th, 2017]
- Alternative Medicine Conferences | Traditional Medicine ... - February 24th, 2017 [February 24th, 2017]
- American Institute of Alternative Medicine - February 24th, 2017 [February 24th, 2017]
- Alternative medicine to treat pain and other ailments on the rise locally - Rockford Register Star - February 25th, 2017 [February 25th, 2017]
- Alternative Medicine Career Information and Education ... - February 27th, 2017 [February 27th, 2017]
- Why is alternative medicine so popular? - Alternative ... - February 27th, 2017 [February 27th, 2017]
- Potential dangers and dubious history of alternative medicine are often unknown to its consumers - MinnPost - February 28th, 2017 [February 28th, 2017]
- New form of alternative medicine comes to OU - Oaklandpostonline - March 1st, 2017 [March 1st, 2017]
- OPENING THE PLAYBOOK ON ALTERNATIVE MEDICINE - Dope Magazine - March 2nd, 2017 [March 2nd, 2017]
- Ask a Doctor: Is there an alternative medicine treatment for constant pain? - Chattanooga Times Free Press - March 7th, 2017 [March 7th, 2017]
- Alternative medicine grows in Sugar Land, Missouri City - Community Impact Newspaper - March 7th, 2017 [March 7th, 2017]
- Medicine with a side of mysticism: Top hospitals promote unproven therapies - STAT - March 7th, 2017 [March 7th, 2017]
- Abstracts: Obamacare Replacement, Alternative Medicine, and More - Undark Magazine - March 8th, 2017 [March 8th, 2017]
- For Prairie Village practitioner, personal experience led to interest in alternative medicine techniques - Shawnee Mission Post - March 8th, 2017 [March 8th, 2017]
- Financial Planning + Alternative Medicine - March 8, 2017 ... - KHTS Radio - March 9th, 2017 [March 9th, 2017]
- Premier U.S. Hospitals Are Selling Unproven Alternative Therapies ... - KQED - March 11th, 2017 [March 11th, 2017]
- Speakers lay stress on use of alternative medicine - The Nation - March 11th, 2017 [March 11th, 2017]
- Top U.S. hospitals promote unproven medicine with a side of ... - PBS - PBS NewsHour - March 11th, 2017 [March 11th, 2017]
- Medical cannabis expert discusses treatment options - Herald-Whig - April 8th, 2017 [April 8th, 2017]
- 5 ALTERNATIVE MEDICINES EVERY MAN SHOULD BE AWARE OF - TORO Magazine - June 6th, 2017 [June 6th, 2017]
- CID unearths fake 'council of alternative medicines' in Behala - Millennium Post - June 11th, 2017 [June 11th, 2017]
- Parents who believe in 'alternative nutrition' convicted after baby dies of malnutrition - Telegraph.co.uk - June 14th, 2017 [June 14th, 2017]
- Times of Malta Alternative medicine - Times of Malta - June 16th, 2017 [June 16th, 2017]
- Suffering from severe pain? Experts say THIS form of alternative medicine will work just as well as drugs! - Zee News - June 20th, 2017 [June 20th, 2017]
- IBAM Indian Board of Alternative Medicine - June 20th, 2017 [June 20th, 2017]
- Alternative medicine practitioner charged with sexual assault in Burlington - Hamilton Spectator - June 20th, 2017 [June 20th, 2017]
- Mind, body, spirit: Nurse opens holistic health store to promote overall wellness - Muscatine Journal - June 21st, 2017 [June 21st, 2017]
- Four of the Most Misused Terms in Alternative Medicine - ATTN: - June 24th, 2017 [June 24th, 2017]
- How cupping therapy helps athletes like Michael Phelps as an alternative medicine - Sport360 - June 26th, 2017 [June 26th, 2017]
- Calimesa Alternative Medicine - Weedmaps - June 26th, 2017 [June 26th, 2017]
- Homeopathic Health Center | Columbus, OH - (614) 890-2589 - June 26th, 2017 [June 26th, 2017]
- Alternative Medicine | What Is Alternative Medicine? - June 26th, 2017 [June 26th, 2017]
- Quotes About Alternative Medicine (30 quotes) - June 26th, 2017 [June 26th, 2017]
- Alternative Medicine That Doctors Recommend | Reader's Digest - June 26th, 2017 [June 26th, 2017]
- Alternative Medicine Schools - Excite Education - June 26th, 2017 [June 26th, 2017]
- Medical journal takes aim at natural remedies - CBC.ca - June 26th, 2017 [June 26th, 2017]
- Healing through alternative medicine: Winona locals choose acupuncture as a cure - Winona Daily News - June 26th, 2017 [June 26th, 2017]
- Patrick Noel, DC: Restoring the body's innate ability to heal through chiropractic care - Colorado Springs Gazette - June 27th, 2017 [June 27th, 2017]
- Back Pain? Try Yoga - New York Times - June 29th, 2017 [June 29th, 2017]
- Jerusalem: Alternative healer indicted on rape charges - The Jerusalem Post - June 29th, 2017 [June 29th, 2017]
- Does Pink Himalayan Salt Have Any Health Benefits? - TIME - June 29th, 2017 [June 29th, 2017]
- Not all wellness is bullshit - Quartz - June 30th, 2017 [June 30th, 2017]
- What's happening in your body during acupuncture? - The Verge - July 1st, 2017 [July 1st, 2017]
- Natural and Alternative Medicine against Asthma - Radio Cadena Agramonte - July 3rd, 2017 [July 3rd, 2017]
- Alternative Medicine in Halacha: a Review - Yeshiva World News - July 3rd, 2017 [July 3rd, 2017]
- West Bengal's top doctors turn out fakes, arrests blow lid off thriving scam - Hindustan Times - July 5th, 2017 [July 5th, 2017]
- Sudbury woman chooses alternative treatments for stage 4 cancer - CBC.ca - July 6th, 2017 [July 6th, 2017]
- Unbiased reporting can help call time on pseudoscience - EuroScientist - July 6th, 2017 [July 6th, 2017]
- Holistic therapy for pets? Traditional vet care being blended with reiki, acupuncture - Georgia Voice - July 7th, 2017 [July 7th, 2017]
- A Memoir of Chronic Fatigue Illustrates the Failures of Medical Research - The New Yorker - July 10th, 2017 [July 10th, 2017]
- Valtrex after expiration - Alternative medicine for herpes simplex 2 - Van Wert independent - July 11th, 2017 [July 11th, 2017]
- Sacred Space, University of Miami partner to educate community on wellness - Miami Herald - July 11th, 2017 [July 11th, 2017]
- One FDA About-Face Doesn't Mean an Orphan-Drug Bonanza - Bloomberg - July 12th, 2017 [July 12th, 2017]
- 'Bridging medicine with nature' - The Torrington Telegram - July 12th, 2017 [July 12th, 2017]
- Gwyneth Paltrow's Goop posted a defense of its jade eggs for vaginas. It's a mess. - Vox - July 14th, 2017 [July 14th, 2017]
- Acupuncture for pets? Yes, it's a thing - MyDaytonDailyNews - July 15th, 2017 [July 15th, 2017]
- Create Ministry for traditional, alternative medicine - Association - Graphic Online - July 17th, 2017 [July 17th, 2017]
- Native American healing class sparks unique health textbook - ABC News - July 18th, 2017 [July 18th, 2017]
- Rav Elyashiv ZTL On Alternative Medicine By R. Yair Hoffman - Yeshiva World News - July 18th, 2017 [July 18th, 2017]
- Expedite action on the passage of the alternative medicine bill ... - GhanaWeb - July 18th, 2017 [July 18th, 2017]
- Is Gwyneth Paltrow's pseudoscience winning? - Vox - July 20th, 2017 [July 20th, 2017]
- Salt Therapy Gaining Popularity in Alternative Medicine Circles - Newsmax - July 22nd, 2017 [July 22nd, 2017]
- Vargas: Weeding out herbal remedies for our pets - News Chief - July 24th, 2017 [July 24th, 2017]
- Patients recognise over-worked GPs as majority agree to see alternative medical professionals - Herald Series - July 25th, 2017 [July 25th, 2017]
- Cancer controversies and traditional medicines - Regina Leader-Post - July 26th, 2017 [July 26th, 2017]